Schedule 13G ownership disclosure

Protagonist Therapeutics Inc

Common Stock, par value $0.00001 · CUSIP: 74366E102

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Deep Track Capital, LP

    Shares: 1,715,691.00 · Class: 2.76%

  • Deep Track Biotechnology Master Fund, Ltd.

    Shares: 1,715,691.00 · Class: 2.76%

  • David Kroin

    Shares: 1,715,691.00 · Class: 2.76%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-25-004833
Form type
SCHEDULE 13G/A
Filer
Deep Track Capital, LP
CIK
CIK 1856083
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub